Literature DB >> 18275077

Analysis of bacterial bowel communities of IBD patients: what has it revealed?

Harry Sokol1, Christophe Lay, Philippe Seksik, Gerald W Tannock.   

Abstract

The bacterial community, in whole or in part, resident in the bowel of humans is considered to fuel the chronic immune inflammatory conditions characteristic of Crohn's disease and ulcerative colitis. Chronic or recurrent pouchitis in ulcerative colitis patients is responsive to antibiotic therapy, indicating that bacteria are the etiological agents. Microbiological investigations of the bacterial communities in stool or of biopsy-associated bacteria have so far failed to reveal conclusively the existence of pathogens or bacterial communities of consistently altered composition in IBD patients relative to control subjects. Confounding factors need to be eliminated from future studies by using better-defined patient populations of newly diagnosed and untreated individuals and by improved sampling procedures.

Entities:  

Mesh:

Year:  2008        PMID: 18275077     DOI: 10.1002/ibd.20392

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  78 in total

Review 1.  Acute and chronic pouchitis--pathogenesis, diagnosis and treatment.

Authors:  Bo Shen
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-04-17       Impact factor: 46.802

2.  Colonic mucosa-associated microbiota is influenced by an interaction of Crohn disease and FUT2 (Secretor) genotype.

Authors:  Philipp Rausch; Ateequr Rehman; Sven Künzel; Robert Häsler; Stephan J Ott; Stefan Schreiber; Philip Rosenstiel; Andre Franke; John F Baines
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-08       Impact factor: 11.205

3.  Assessing gut microbial diversity from feces and rectal mucosa.

Authors:  Ana Durbán; Juan J Abellán; Nuria Jiménez-Hernández; Marta Ponce; Julio Ponce; Teresa Sala; Giuseppe D'Auria; Amparo Latorre; Andrés Moya
Journal:  Microb Ecol       Date:  2010-08-24       Impact factor: 4.552

4.  [New therapeutic approaches to special diseases of the small intestine].

Authors:  M Schumann; K Herrlinger; M Zeitz; E F Stange
Journal:  Internist (Berl)       Date:  2010-06       Impact factor: 0.743

5.  Real-time analysis of mucosal flora in patients with inflammatory bowel disease in India.

Authors:  Ravi Verma; Anil Kumar Verma; Vineet Ahuja; Jaishree Paul
Journal:  J Clin Microbiol       Date:  2010-09-22       Impact factor: 5.948

Review 6.  Bacterial-mucosal interactions in inflammatory bowel disease: an alliance gone bad.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2008-10-16       Impact factor: 4.052

Review 7.  Faecalibacterium prausnitzii: from microbiology to diagnostics and prognostics.

Authors:  Mireia Lopez-Siles; Sylvia H Duncan; L Jesús Garcia-Gil; Margarita Martinez-Medina
Journal:  ISME J       Date:  2017-01-03       Impact factor: 10.302

8.  Metabolic alterations to the mucosal microbiota in inflammatory bowel disease.

Authors:  Michael Davenport; Jordan Poles; Jacqueline M Leung; Martin J Wolff; Wasif M Abidi; Thomas Ullman; Lloyd Mayer; Ilseung Cho; P'ng Loke
Journal:  Inflamm Bowel Dis       Date:  2014-04       Impact factor: 5.325

Review 9.  Microbiota and the gut-liver axis: bacterial translocation, inflammation and infection in cirrhosis.

Authors:  Valerio Giannelli; Vincenza Di Gregorio; Valerio Iebba; Michela Giusto; Serena Schippa; Manuela Merli; Ulrich Thalheimer
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

10.  Effects of different complementary feeding regimens on iron status and enteric microbiota in breastfed infants.

Authors:  Nancy F Krebs; Laurie G Sherlock; Jamie Westcott; Diana Culbertson; K Michael Hambidge; Leah M Feazel; Charles E Robertson; Daniel N Frank
Journal:  J Pediatr       Date:  2013-02-26       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.